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Abstract
START-dependent transcription in Saccharomyces cerevisiae is regulated by two transcription factors SBF and MBF, whose
activity is controlled by the binding of the repressor Whi5. Phosphorylation and removal of Whi5 by the cyclin-dependent
kinase (CDK) Cln3-Cdc28 alleviates the Whi5-dependent repression on SBF and MBF, initiating entry into a new cell cycle.
This Whi5-SBF/MBF transcriptional circuit is analogous to the regulatory pathway in mammalian cells that features the E2F
family of G1 transcription factors and the retinoblastoma tumor suppressor protein (Rb). Here we describe genetic and
biochemical evidence for the involvement of another CDK, Pcl-Pho85, in regulating G1 transcription, via phosphorylation
and inhibition of Whi5. We show that a strain deleted for both PHO85 and CLN3 has a slow growth phenotype, a G1 delay,
and is severely compromised for SBF-dependent reporter gene expression, yet all of these defects are alleviated by deletion
of WHI5. Our biochemical and genetic tests suggest Whi5 mediates repression in part through interaction with two histone
deacetylases (HDACs), Hos3 and Rpd3. In a manner analogous to cyclin D/CDK4/6, which phosphorylates Rb in mammalian
cells disrupting its association with HDACs, phosphorylation by the early G1 CDKs Cln3-Cdc28 and Pcl9-Pho85 inhibits
association of Whi5 with the HDACs. Contributions from multiple CDKs may provide the precision and accuracy necessary to
activate G1 transcription when both internal and external cues are optimal.
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Introduction
Cyclin-dependent proteinkinases(CDKs) act asmolecularmachines
that drive cell division, and cell cycle progression is dependent on
oscillation between CDK active and inactive states. In S. cerevisiae,t h e
CDK Cdc28 associates with nine different cyclin subunits to promote
and coordinate a complex network of events necessary for smooth cell
cycle transitions [1]. Irreversible commitment to a new round of cell
division occurs toward the end of G1 phase in a process called Start in
yeast. The analogous regulatory event is called the restriction point in
mammalian cells [2,3]. In yeast, three G1 cyclins, Cln1, Cln2, and
Cln3, associate with Cdc28 to initiate events required for progression
through Start. Passage through Start catalyzes a defined molecular
program that initiates DNA replication, budding, spindle maturation,
and chromosome segregation [3].
One key feature of Start in yeast, and G1 progression in other
eukaryotic cells, is the induction of a transcriptional program
involving over 200 genes, including those encoding the G1 (CLN1,
CLN2, PCL1, and PCL2) and B-type cyclins (CLB5 and CLB6)
[4,5]. G1/S phase-specific transcription depends on two hetero-
dimeric transcription factors called SBF (Swi4,6 cell cycle box
binding factor) and MBF (MluI binding factor). These complexes
share a common regulatory subunit, Swi6, which is tethered to
DNA via its binding partners, encoded by SWI4 in SBF and MBP1
in MBF [5]. At the well-studied HO locus, binding of the zinc-
finger transcription factor Swi5 is followed by recruitment of the
Swi/Snf chromatin remodeling complex and the SAGA histone
acetyltransferase complex [6–8]. These events set the stage for SBF
binding and recruitment of the SRB/mediator complex [6].
Importantly, subsequent recruitment of PolII and transcription
initiation is dependent on CDK activity [9]. Although any one of
the three G1 cyclins is sufficient to drive Start, genetic studies
indicate a key role for Cln3-Cdc28 in activating SBF and MBF. At
the same time Cln1 and Cln2 are required for the proper
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synthesis. Cells lacking CLN3 are large and severely delayed for
onset of G1/S transcription, while ectopic induction of CLN3 in
small G1 cells activates transcription and accelerates passage
through Start [10].
Start does not occur until cells have passed a critical cell size
threshold, a barrier modulated by nutrient conditions, among
other regulatory inputs [11]. A systematic analysis of cell size
profiles for the entire set of yeast deletion mutants uncovered
many new regulators of Start including Whi5 and implicated it as
an inhibitor of G1/S-specific transcription [12,13]. Whi5 occupies
specific promoters early in G1 phase when CDK activity is low.
However, Cdc28-dependent phosphorylation of both Whi5 and
SBF/MBF late in G1 phase results in disengagement from SBF
and nuclear export of Whi5 consequently leading to activation of
SBF- and MBF-dependent transcription [12,13].
Whi5 is proposed to function in a manner analogous to the well-
characterized Rb family proteins in metazoans. E2F, the
functional analog of SBF/MBF, regulates G1-specific gene
expression required for passage through the restriction point
[14]. E2F activity is restricted to late G1 phase because of
inhibition by the retinoblastoma protein (Rb). Rb associates with
E2F to restrain its activity until late G1, at which point stepwise
phosphorylation of Rb by two CDKs, cyclin D-Cdk4/6 and cyclin
E-Cdk2, causes the dissociation of Rb from E2F [15]. This process
appears to be regulated by a positive feedback loop in which Rb
phosphorylation by cyclinE-Cdk2 leads to further dissociation of
Rb from promoters and enhancement of G1-transcription. At the
molecular level, Rb interacts with both E2F and chromatin
remodeling complexes such as histone deacetylases (HDACs) [16–
18]. Rb appears to repress transcription through at least three
distinct mechanisms: (1) Rb can bind directly to the activation
domain of E2F thereby blocking its activity [19]; (2) recruitment of
Rb can block the assembly of the pre-initiation complex thus
inhibiting the activity of adjacent transcription factors [20] and; (3)
Rb can recruit remodelers such as HDAC1 and BRG1 to modify
chromatin structure. BRG1 is one of the human Swi/Snf
adenosine triphosphatases (ATPases) that remodel nucleosomes
by utilizing ATP to weaken the interactions between DNA and
histones [16,17]. The specific roles of different CDKs in regulating
E2F-Rb function, however, remain unclear.
Another yeast CDK Pho85 was originally discovered as a
regulator of phosphate metabolism, but has since been shown to
play numerous roles in the regulation of cell division and other
processes [21–23]. Ten genes encoding Pho85 cyclins (Pcls) have
been identified and they appear to dictate substrate and functional
specificity of Pho85 [24–26]. Expression of three Pcls, PCL1,
PCL2, and PCL9, is restricted to G1 phase of the cell cycle [25].
Specifically, PCL9 expression peaks early in G1, whereas maximal
expression of PCL1 and PCL2 is observed at Start and is dependent
largely on SBF [27–29]. Although Pho85 is not essential for
viability, it is required for cell cycle progression in the absence of
the Cdc28 cyclins CLN1 and CLN2 [29], and its absence leads to
catastrophic morphogenic changes that culminate in a G2 arrest
[30]. Consistent with this observation, inactivation of both Cdc28
and Pho85 CDKs specifically inhibits expression of G1-regulated
genes involved in polarized growth [31].
As noted above, transcriptional repression by Rb has been
linked to its interaction with histone modification complexes, in
particular HDACs. Recent work highlights the importance of post-
translational modifications of histone and nucleosome positioning
in regulating gene expression [32,33]. Histone acetylation
neutralizes the positive charge generated by lysine-rich regions
present in the N-terminal tails of histones, thereby disrupting
nucleosome structure and increasing promoter accessibility [34].
As a result, many transcription activators have been shown to
interact with histone acetyltransferases, whereas transcriptional
repressors often associate with HDACs to promote nucleosome
formation to occlude transcription factor binding [35,36]. Histone
deacetylation in S. cerevisae is mediated by a family of HDACs
including Rpd3, Hda1, Hda2, Hos1, Hos2, and Hos3 [37].
Similar to their mammalian counterparts, some yeast HDACs are
recruited to promoters by sequence-specific regulatory factors to
repress gene expression. For example, the Rpd3 deacetylase
complex is recruited to the INO1 promoter by the DNA binding
protein Ume6 [35,38–40]. This recruitment results in local histone
deacetylation and repression of INO1 gene expression [41]. Hda1
is another example of this type of regulation, and is recruited to its
target promoters by the repressor Tup1 [42].
In this study, we provide detailed mechanistic insights into
Whi5-dependent regulation of G1-specific transcription and cell
cycle progression. Specifically, we identify Whi5, to our knowl-
edge, as the first demonstrated physiological substrate for the G1-
specific Pcl9-Pho85 CDK and provide genetic and biochemical
evidence supporting a direct role for Pho85 at Start. Furthermore,
we show that in a manner similar to Rb in mammalian cells,
Whi5-mediated repression involves the HDACs Rpd3 and Hos3.
Dual phosphorylation of Whi5 by Cdc28 and Pho85 inhibits Whi5
activity in at least two ways. Both kinases appear to regulate
interaction of Whi5 with different HDACs, whereas Cdc28 is also
involved in disrupting Whi5 association with SBF and promoting
its nuclear export [12,13]. G1-specific CDKs thus are specialized
to regulate different aspects of the same critical cell cycle event—
inhibition of Whi5—resulting in definitive inactivation of the Whi5
repressor.
Author Summary
Eukaryotic cells grow and divide by progressing through
carefully orchestrated stages of the cell cycle characterized
by stage-specific patterns of gene expression, DNA
replication, and scission. How stage-specific gene expres-
sion is coordinated with cell cycle progression is only
partially understood. The phase known as G1 marks the
initiation of the cell cycle (called START in yeast) and
involves the coordinated expression of more than 200
genes regulated by two transcription factors, SBF and MBF.
The activity of SBF and MBF is restrained by binding of the
repressor protein Whi5 to the two transcription factors
early in G1 phase. Phosphorylation of Whi5 by G1-specific
forms of the cyclin-dependent kinase (CDK) Cdc28
promotes dissociation of Whi5 from SBF and its export
from the nucleus; this, in turn, releases SBF to activate G1-
specific transcription. This G1 transcriptional circuit is
analogous to that defined in mammals by the E2F family of
transcription factors and the retinoblastoma (Rb) tumor
suppressor protein. Rb further contributes to the repres-
sion of G1-specific transcription in mammals by recruiting
histone deacetylases (HDACs), which are chromatin
remodeling complexes that regulate promoter accessibil-
ity. Here, we show that regulation of G1-specific transcrip-
tion in yeast also involves repressor-mediated recruitment
of HDACs. We demonstrate that repression by Whi5 is
modulated by both Cln-Cdc28 and a second G1-specific
CDK, Pcl-Pho85, and further show that both kinases
regulate the interaction of Whi5 with HDACs. We propose
that regulation of the repressor by more than one G1-
specific CDK ensures definitive inactivation of Whi5, a
critical event for appropriate cell cycle initiation.
CDKs, G1 Transcription, and HDACs
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A Synthetic Dosage Lethality Screen Identifies Whi5 as a
Putative Substrate for the CDK Pho85
Synthetic dosage lethality (SDL) is a genetic assay that is based
on the rationale that increasing levels of a protein may have no
effect on the growth of an otherwise wild-type (wt) strain but may
cause a measurable phenotype—such as lethality—in a mutant
strain with reduced activity of an interacting protein [43,44].
Previous studies suggest that SDL can be used effectively to
identify novel enzyme targets and a genome-wide SDL screen in
cells lacking Pho85 identified known targets of the CDK [23]. In
addition to known substrates, several putative Pho85 targets were
also identified, including the G1-specific transcription repressor
Whi5 [24]. To further explore the role of Pho85 in G1 phase-
specific transcription we examined the WHI5-PHO85 SDL
interaction in greater detail. As noted previously, Pho85 activity
and substrate specificity depends on its interaction with cyclin
subunits known as Pcls [25]. To implicate specific Pcl-Pho85
complexes in modulating Whi5 function we examined the effects
of WHI5 overexpression in cells lacking different Pcls (Figure 1).
Similar to effects observed in cln3D and cln1D cln2D mutants [13],
overexpression of WHI5 resulted in growth inhibition of pcl1D and
pcl9D deletion strains and this growth defect was exacerbated in a
pcl1D pcl9D double mutant (Figure 1). Unlike pcl1D or pcl9D
mutants, strains lacking PCL2 or PHO80 cyclins were not
adversely affected by increased WHI5 dosage suggesting that the
WHI5-PHO85 genetic interaction is dependent on the PCL1,2
cyclin subfamily and more specifically on PCL1 and PCL9
(Figure 1). This observation is consistent with the fact that Pcl1
and Pcl9 (but not Pcl2) are the two G1-specific cyclins that localize
to the nucleus [30,45]. The growth phenotype seen in the plating
assay was confirmed by measuring growth rates in liquid culture
(unpublished data). On the basis of these results, Pcl1/9-Pho85
may contribute to Whi5 regulation in a manner similar to Cln3-
Cdc28.
Whi5 Is a Substrate for Pcl9-Pho85 Phosphorylation
The genetic interactions described above suggest Whi5 may be
a direct target of Pho85. Evidence supporting this hypothesis is
provided by protein microarray assays where Whi5 is phosphor-
ylated in vitro by Pcl1-Pho85 [46]. We characterized the Whi5-
Pho85 interaction biochemically by performing in vitro kinase
assays using recombinant Pcl-Pho85 CDK complexes and purified
Whi5 as substrate (Figure 2A). Incorporation of [
32P] into Whi5
was not detected in the absence of CDKs (Figure 2A, lane 4).
However, Whi5 phosphorylation was observed in the presence of
Pcl1- and Pcl9-Pho85 (Figure 2A, lanes 1,2) and when compared
to Cln2-Cdc28 kinase activity, Pho85 and Cdc28 phosphorylated
Whi5 at similar levels in vitro (Figure 2A, lanes 1–3).
Previous studies revealed multiple Whi5 slow-migrating isoforms
that correlate with its phosphorylation state [12,47]. We examined
the effect of various cyclin or CDK mutants on Whi5 mobility
(Figure 2B). Because of genetic redundancy of Pcl cyclins [27], we
were unable to reproducibly detect changes in Whi5 phosphoforms
in cyclin mutant strains. Therefore, a Pho85 mutant was used to
Figure 1. WHI5 overexpression is toxic to strains compromised for Pho85 CDK activity. Isogenic wt (BY263), pho85D (BY391), pcl1D
(BY628), pcl2D (BY451), pcl9D (BY694), pcl1D pcl9D (BY760), and pho80D (BY490) strains bearing either GAL1-WHI5 (pBA1973) or empty vector control
(pEG-H) were spotted in serial 10-fold dilutions on galactose media and incubated for 72 h at 30uC.
doi:10.1371/journal.pbio.1000188.g001
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findings [12,13], slow migrating Whi5 isoforms present in
asynchronous wt extracts (Figure 2B, lane 1) were modestly reduced
in cells lacking CLN3 (Figure 2B, lane 7) and completely absent in a
cln1D cln2D double mutant (Figure 2B, lane 6), confirming that
Whi5 phosphorylation depends on Cln-Cdc28 kinase complexes.
Consistent with our SDL results and in vitro kinase assays, we
observed a significant reduction in Whi5 mobility in extracts from a
pho85 mutant strain (Figure 2B, lane 2). Thus, similar to Cdc28,
phosphorylation of Whi5 also depends on Pho85 in vivo.
To determine if Whi5 physically associates with Pho85 in yeast,
we first assayed Whi5
FLAG immune complexes for kinase activity.
A robust autophosphorylation activity was recovered from
Whi5
FLAG immunoprecipitates derived from wt cell extracts when
radiolabeled ATP was added to the immunoprecipitated sample
(Figure 2C, lane 2). This activity was partially dependent on both
CDC28 and PHO85 (Figure 2C, lanes 3–5). We also confirmed a
physical interaction between Whi5 and Pcls using a co-
immunoprecipitation assay (Figure 2D). Immunoprecipitation of
Whi5
MYC from epitope-tagged cyclin extracts revealed a specific
Pcl1
HA
Pcl2
HA
Pcl9
HA
Pho80
HA
Figure 2. Whi5 is a substrate for Pcl9-Pho85 CDK-dependent phosphorylation. (A) In vitro phosphorylation of Whi5 by Pho85 kinase.
Purified Whi5
GST and c-
32P-ATP were incubated alone (lane 4) or in the presence of recombinant Pcl1-Pho85 (lane 1), Pcl9-Pho85 (lane 2), or Cln2-
Cdc28 (lane 3) kinases. Phosphorylated Whi5 protein was resolved by SDS-PAGE and autoradiography. (B) Slower-migrating forms of Whi5 are
dependent on Cdc28 and Pho85. Cell extracts were prepared from wt (BY2507, lane 1), pho85D (BY4152, lane 2), cdc28-4 (BY4153, lane 4), cdc28-4
pho85D (BY4154, lane 5), cln1D cln2D (BY4289, lane 6), and cln3D (BY4288, lane 7) strains expressing WHI5
MYC along with a whi5D control strain
(BY4454, lane 3). Cells were grown at 30uC (semipermissive temperature for cdc28-4 strains) to log phase (Optical Density [OD]=0.6) before
harvesting. cdc28-4 cells were placed at 37uC for 2 h to inactivate Cdc28 before harvesting. Whi5
MYC mobility was assessed by immunoblotting. (C)
Whi5 associates with Pho85-dependent kinase activity. Wt (BY263) (lane 2), cdc28-4 (BY465) (lane 3), cdc28-13 (BY462) (lane 4), or pho85D (BY867)
(lane 5) strains bearing a GAL-WHI5
FLAG plasmid (pMT3586) or control vector control (pMT3164) were grown at 30uC (semipermissive temperature for
cdc28-4 and cdc28-13 strains) in galactose media for 3 h. Whi5 complexes were recovered on anti-FLAG resin, incubated in kinase buffer with c-
32P-
ATP at 30uC and resolved by SDS-PAGE. Capture of Whi5 protein was detected with anti-FLAG antibody. (D) Whi5 interacts with the Pcl, Pcl9. Anti-
MYC immune precipitates of WHI5
MYC strain lysates (BY2507) bearing either PCL1
HA (pBA1820, lane 2), PCL2
HA (pBA1821, lane 3), PCL9
HA (pBA1822,
lane 4), PHO80
HA (pBA1823, lane 5), or a vector control (pBA330v, lane 1) were probed with 9E10 anti-MYC and 12CA5 anti-HA antibodies. The black
lines in (A, B, and D) indicate empty lanes that were removed from the original blot.
doi:10.1371/journal.pbio.1000188.g002
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to reproducibly detect a physical interaction between Whi5 and
Pcl1 (Figure 2D, lane 2) suggesting that Pcl9-Pho85 is the primary
Whi5 CDK. Taken together, the phosphorylation and co-
immunoprecipitation assays strongly suggest that, in addition to
Cdc28, Pho85 also phosphorylates Whi5. Furthermore these
results identify Whi5 as the first reported substrate for Pcl9-Pho85,
one of two Pcls whose activity is restricted to early G1 phase.
Whi5 associates indirectly with G1 phase-regulated promoters
through interaction with SBF and MBF. Interactions with these
transcription factors and subsequent promoter binding are
disrupted by CDK-dependent phosphorylation [12,13]. Because
Whi5 appears to be a Pho85 substrate, we assessed the occupancy
of SBF promoters by Pcl9. To date, cyclins have not been detected
at yeast promoters. Pcl9 is normally an unstable short-lived protein
[27]; however, similar to other cyclins, Pcl9 turnover appears to be
catalyzed in part by its cognate CDK, Pho85 (Figure 3A) [48].
Therefore, to test Pcl9 promoter localization in a more sensitive
genetic background, we performed ChIP (Chromatin immuno-
precipitation) experiments in a pho85D strain (Figure 3B). The
highest levels of CLN2 promoter DNA were detected in Pcl9
MYC
immune complexes 30 min following release from a metaphase-
anaphase arrest (Figure 3B). The Pcl9-chromatin association was
no longer detectable 45 min after GAL-CDC20 induction indicat-
ing that the interaction is short-lived and transient as predicted for
a regulator of Start. The association was Whi5-dependent since
Pcl9 was not detected at the CLN2 promoter in a strain lacking
Whi5 (Figure 3C). The localization of Pcl9 to CLN2,aG 1
promoter, is consistent with a direct role for Pcl9-Pho85 in
regulating G1 transcription.
Pcl9-Pho85 Regulates Whi5 Function via Phosphorylation
As mentioned above, cln3D mutants arrest in G1 phase as large
unbudded cells in response to increased WHI5 dosage, indicating
that Whi5 is a dose-dependent regulator of Start. Therefore, if
Pho85 and Cdc28 function analogously to inhibit Whi5 activity,
we predict that elevated Pho85 kinase activity would antagonize
the toxic effects of WHI5 overexpression and suppress the growth
defects observed in a cln3D mutant. To test this prediction, high
copy plasmids expressing PCL1, PCL2, PCL9,o rPHO80 were
introduced into a cln3D strain expressing WHI5 from a conditional
MET25 promoter (Figure 4A). Plasmid-based expression of Pcls
and Whi5 was confirmed by immunoblotting (Figure S1).
Induction of WHI5 expression in a cln3D mutant resulted in cell
death whereas overexpression of PCL1 or PCL9 partially
suppressed this toxicity and restored growth (Figure 4A). Consis-
tent with results from SDL analyses (Figure 1), this suppression was
specific to PCL1 and PCL9 since neither PCL2 nor PHO80 were
able to function effectively in the assay (Figure 4A). Furthermore,
PCL1/9-mediated suppression was dependent on phosphorylation
since growth of a cln3D mutant expressing a nonphosphorylatable
form of WHI5 (Whi512A) [13] could not be restored (Figure 4A).
These genetic results corroborate the biochemical evidence that
Pcl-Pho85 regulates Whi5 activity through phosphorylation.
Given its effect on WHI5 overexpression, we next examined PCL
effects on other CLN3-associated phenotypes. CLN3 is required to
activate G1-specific transcription once cells have achieved a critical
size [49–51]. A cln3D mutant exhibits a large cell size phenotype
because of its inability to inhibit Whi5 and activate Start-specific
transcription [12,13]. Ectopic expression of PCL1 or PCL9 reduced
cln3D cell size to an intermediate level between that of wt and cln3D
cells (Figure 4B). Conversely, deletion of PCL9, PCL1, and the
partially redundant cyclin PCL2 resulted in a cell size increase
(Figure 4C). These results suggest that Pcl-Pho85 and Cln3-Cdc28
share a common role in cell cycle progression to regulate Whi5
activity and promote passage through Start.
CDC28 and PHO85 Function in Parallel Pathways to
Regulate Whi5 Function
To determine if Pcl-Pho85 and Cln3-Cdc28 might function in
parallel to regulate Start, we first tried to test whether pcl9D cln3D
or pcl1D pcl9D cln3D strains showed any synthetic growth defects.
As expected, no growth defects were observed, probably because
of the redundant effects of other Pcls [27]. Unlike the Cdc28
cyclins, which shows distinct cell cycle expression patterns, most
Pcls are expressed at all cell cycle stages [25]. We then examined
the phenotype of a pho85D cln3D double mutant. Cells lacking
cln3D are larger than wt cells but do not display overt defects in
growth rate while pho85D mutants are slow growing (Figure 5A).
However, pho85Dcln3D double mutants exhibited a more pro-
nounced growth defect compared to single mutants and analysis of
DNA content revealed that the pho85D cln3D double mutant cells
accumulated in G1 phase with predominantly unreplicated DNA
(Figure 5A). Importantly, deleting WHI5 overcame both the cell
cycle progression and growth defects observed in the absence of
both CLN3 and PHO85. Notably, a pho85D cln3D whi5D triple
mutant exhibited a growth rate similar to a cln3D single mutant
indicating that Pcl-Pho85 and Cln3-Cdc28 function in separate
yet converging pathways to regulate Whi5 function and, by
extension, G1 cell cycle progression (Figure 5A). These observa-
tions also hold true under liquid growth conditions as shown.
WHI5-dependent suppression appears to be specific to the pho85D
cln3D phenotype because WHI5 deletion was unable to rescue 53
additional synthetic lethal interactions involving PHO85 (Table S1;
D.Q. Huang and B.J. Andrews, unpublished data).
Given that Whi5 represses SBF- and MBF-specific transcrip-
tion, we asked whether PHO85 affects SBF-driven reporter gene
expression. A reporter gene consisting of tandem SCB consensus
element repeats fused upstream of the HIS3 coding region was
constructed and integrated into wt, cln3D, and pho85D strains.
Previous work has shown that this reporter provides a highly
specific read-out for SBF-dependent transcription [13,52]. Growth
on medium lacking histidine supplemented with 3-aminotriazole
(3-AT) was used to assess SBF transcriptional activity (Figure 5B).
Even though cells lacking PHO85 were moderately sensitive to
higher concentration (5 mM) of 3-AT (unpublished data), both
cln3D and pho85D mutants showed no growth in media containing
30 mM 3-AT indicating that SBF transcription is impaired in
these mutants, whereas growth of wt cells was unaffected [13].
Furthermore, defects in SCB-driven gene expression were more
pronounced in the pho85D cln3D double mutant (at 10 mM 3-AT,
Figure 5B). Consistent with the genetic interactions described
above (Figure 5A), SBF-dependent reporter activity was restored
in pho85D cln3D mutants when WHI5 was deleted (Figure 5B).
However, WHI5 deletion only partially rescued the growth defect
in pho85D cells at 30 mM of 3-AT (Figure 5B). The Whi5-
independent 3-AT sensitivity of pho85D cells may be due to
unregulated Gcn4 in the absence of PHO85, since GCN4 is
induced by 3-AT and Pho85 has been shown to regulate Gcn4
stability [53,54]. Nonetheless, these data suggest that, like Cln3-
Cdc28, Pcl-Pho85 modulates SBF activity through Whi5.
We next interrogated the effects of CDK activity on Whi5-
mediated transcriptional repression (Figure 6). A construct
expressing a LexA DNA binding domain fused to WHI5 was
introduced into a strain harboring a LacZ reporter gene containing
LexA binding sites in its promoter (Figure 6). Consistent with its
role as a negative regulator of G1-specific transcription, a ,10-
fold reduction in b-galactosidase activity was observed in cells
CDKs, G1 Transcription, and HDACs
PLoS Biology | www.plosbiology.org 5 September 2009 | Volume 7 | Issue 9 | e1000188Figure 3. Pcl9 localizes to G1-specific promoters in a cell cycle-dependent manner. (A) Pho85 regulates Pcl9 protein stability. Wt (BY263)
and pho85D strains (BY391) harboring a GAL1-PCL9
HA plasmid (pBA2112) were grown to exponential phase in galactose media (lane 1). PCL9
expression was repressed by addition of glucose to final concentration of 2% and cells were harvested 10 (lane 2), 30 (lane 3), and 90 (lane 4) min
after addition of glucose. Pcl9 abundance was assessed by immunoblotting using 12CA5 anti-HA antibodies. (B) Pcl9 localizes to SBF-dependent
promoters. An exponentially growing GAL1-CDC20 pho85DPCL9
MYCstrain (BY4148, lane 1) was arrested at M/G1 phase in glucose-containing medium
(lane 2). Cultures were harvested 15 (lane 3), 30 (lane 4), 45 (lane 5), and 60 (lane 6) min after release from CDC20-induced arrest in galactose medium.
Cell cycle progression was monitored by FACS analysis. Anti-MYC and anti-Swi6 ChIPs from the indicated strains were analyzed for CLN2 promoter
sequences by quantitative RT-PCR. (C) In a strain lacking Whi5, GAL1-CDC20 pho85D whi5DPCL9
MYC, Pcl9 no longer localizes to the CLN2 promoter.
Anti-Swi4 ChIPs are shown as a positive control.
doi:10.1371/journal.pbio.1000188.g003
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control (Figure 6). Overexpression of PCL9, CLN3,o rCLN2
restored LacZ expression to intermediate levels indicating that
activation of either CDC28 or PHO85 was capable of antagonizing
Whi5 function in this assay (Figure 6). Consistent with suppression
of WHI5-mediated growth defects (Figure 4), inhibition of Whi5
activity was dependent on phosphorylation since LacZ expression
could not be restored in cells harboring an unphosphorylatable
LexA-Whi5
12A fusion protein (Figure 6).
Pho85 Does Not Regulate Whi5 Localization or Its
Interactions with G1-Specific Transcription Complexes
Cln2-Cdc28 activity was previously shown to disrupt recombi-
nant Whi5-SBF complexes in vitro [13], but Cln3-Cdc28 and
Pho85 kinases had not been assessed for this activity. A
preassembled recombinant Whi5-Swi4
FLAG-Swi6 complex bound
to anti-FLAG resin was incubated with purified kinases in the
presence of radiolabeled ATP and separated into soluble
(Figure 7B, labeled ‘‘S’’) and bound fractions (Figure 7B, labeled
Figure 4. PHO85 affects growth and cell size defects associated with cln3D. (A) Ectopic PCL1 and PCL9 expression alleviates WHI5 toxicity in a
cln3D strain. A cln3D strain (BY653) bearing a methionine-repressible WHI5
GST (pBA1975) or WHI5
12A-GST low-copy plasmid (pBA2249) along with an
additional vector control (pBA330v), PCL1
HA (pBA1820), PCL2
HA (pBA1821, PCL9
HA, pBA1822), or PHO80
HA (pBA1823) construct were spotted in serial
10-fold dilutions on media supplemented with or lacking methionine (WHI5 ‘‘OFF’’, WHI5 ‘‘ON,’’ respectively) and incubated for 72 h at 30uC. (B) PCL1
and PCL9 cyclins modulate cell size. Cell size distributions were analyzed for wt (BY263) and cln3D strains (BY653) bearing vector control (pBA330v),
PCL9
HA (pBA1822), or PCL1
HA (pBA1820) plasmids. The median cell volume based on three replicates was: 42.33 fl61.13 (wt+vector control);
71.78 fl61.43 (cln3D+vector control); 55.67 fl61.66 (cln3D+PCL1); 54.25 fl61.21 (cln3D+PCL9). (C) Cells lacking PHO85 G1 cyclins exhibit an enlarged
cell size. Cell size distributions were analyzed for wt (BY263), pcl1D pcl2D pcl9D (BY764), and cln3D strains (BY653). The median cell volume based on
three replicates was: 46.73 fl60.63 (wt); 53.96 fl60.75 (pcl1D pcl2D pcl9D); 72.72 fl61.22 (cln3D).
doi:10.1371/journal.pbio.1000188.g004
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PLoS Biology | www.plosbiology.org 7 September 2009 | Volume 7 | Issue 9 | e1000188Figure 5. PHO85 regulates G1 transcription via WHI5. (A) The G1 delay phenotype associated with a cln3D pho85D strain is dependent on WHI5.
Wt (BY263), cln3D (BY653), pho85D (BY391), cln3D pho85D (BY4291), and cln3D pho85D whi5D (BY4292) strains were spotted in serial 10-fold dilutions
on rich media (YPED) and incubated for 24 h at 30uC. DNA content of exponentially growing cultures was determined by FACS analysis. Liquid
growth assays were also performed for these strains and growth rate is reported relative to wt as shown in the bar graph. Graphical representations
of growth rates are shown above the bar graph as line plots, where the upper red line represents the growth of WT and the black line shows the
growth of each mutant. (B) A cln3D pho85D strain exhibits defects in SCB-driven gene expression. Wt (BY4302), cln3D (BY4303), pho85D (BY4304),
cln3D pho85D (BY4305), cln3D pho85D whi5D (BY4306), pho85Dwhi5D (BY4308), and cln3Dwhi5D (BY4307) strains harboring an integrated SCB-HIS3
reporter were spotted in serial 10-fold dilutions on histidine-containing medium or media lacking histidine and supplemented with 10 or 30 mM 3-
AT. Plates were incubated at 30uC for 48 h. We note that the synthetic growth defect of a cln3 pho85 mutant is most pronounced on rich medium (A),
and is not as evident when strains are grown on minimal medium.
doi:10.1371/journal.pbio.1000188.g005
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basis of in vitro kinase activity (Figure 7A, and Materials and
Methods). As expected, Cln2-Cdc28 phosphorylation caused most
of the SBF-bound Whi5 to be released into the soluble fraction
(Figure 7B, lanes 3 and 4). In contrast, we failed to observe
dissociation of Whi5 from SBF in the presence of Cln3- or Pcl9-
CDK complexes (Figure 7B, lanes 5–10). In addition to negatively
regulating the interaction of Whi5 with SBF, Cdc28 also controls
its localization [13]. Unlike Cln-Cdc28 phosphorylation, which
promotes Whi5 export from the nucleus, deletion of PHO85 did
not dramatically affect the subcellular localization of Whi5
(Figure 7C). Together, these results suggest that Pho85 must
regulate Whi5 function through alternate mechanisms.
Mechanism for Whi5-Mediated Transcriptional
Repression by Pho85
We next explored what additional mechanism might explain
Pcl- and Cln3-mediated regulation of Whi5 activity. Functional
conservation clearly extends to Whi5 and its metazoan analogue
Rb [14]. Since Rb represses transcription, in part, through
recruitment of HDACs, we used a batch affinity chromatography
assay to test for physical interactions between a Whi5
GST ligand
and tandem affinity tagged HDACs (Figure 8A). Specific
interactions between Whi5 and Hos3, Rpd3, and, to a lesser
extent, Hos1 were identified (Figure 8A, lanes 1, 5, 13) suggesting
that, like Rb, Whi5-dependent transcriptional repression involves
recruitment of HDACs. This observation is consistent with
previous work that detected Rpd3 at the PCL1 promoter using a
ChIP assay [55]. Furthermore, HOS3 and RPD3 were required for
WHI5 dose-dependent effects on cell size. Like wt cells, strains
lacking either HOS3 (Figure 8B, panel 1) or RPD3 (Figure 8B,
panel 2) also exhibited a dose-dependent increase in cell size in
response to WHI5 overexpression. However, additional cell size
effects were not observed in strains lacking both HDACs,
suggesting that Hos3 and Rpd3 regulate Whi5 function synergis-
tically (Figure 8B, panel 3).
If HDACs are required for Whi5 function, then strains lacking
HDAC function should be resistant to toxic effects associated with
WHI5 overexpression. Consistent with this prediction, the growth
defect caused by WHI5 overproduction in a cln3D was alleviated
by the deletion of HOS3 and RPD3 (Figure 9A). Deletion of HOS3
alone rescued WHI5 toxicity in a pho85D strain while a cln3D
mutant required deletion of both HOS3 and RPD3 in order to
tolerate increased dosage of WHI5 (Figure 9A).
Given that Whi5 appears to be acting through HDACs, we
predicted that deletion of HOS3 and RPD3 should phenocopy
those genetic interactions seen in whi5D mutants. We first tested
various HDAC deletion strains for suppression of the slow growth
phenotype of a pho85Dcln3D mutant. As for WHI5, deletion of
HOS3 and RPD3 partially suppressed the growth defect seen in the
pho85Dcln3D double mutant strain (Figure 9B). Suppression was
specific to HOS3 and RPD3 because deletion of other HDACs
showed no suppression, and the growth rate of the pho85Dcln3D-
hos3D strain was not improved by subsequent deletion of RPD3
and vice versa (Figure 9B).
We next asked if deletion of HDACs might overcome the Start
arrest seen in cells lacking both CLN3 and BCK2, another regulator
of G1 transcription that functions in parallel with CLN3 [56]. A
cln3Dbck2Dwhi5D triple mutant grows as vigorously as wt, placing
WHI5 downstream of both upstream activators of G1 transcrip-
tion [13]. Interestingly, deletion of RPD3 partially restored growth
in the cln3Dbck2D strain providing further evidence for an HDAC
requirement in Whi5-mediated transcriptional repression
(Figure 9C). Neither subsequent deletion of HOS3 nor deletion
of other HDACs affected growth appreciably (Figure 9C). We also
employed the SCB-HIS3 assays used above to explore SBF-driven
reporter gene expression in the HDAC mutants (Figure 10). As
expected, deletion of RPD3 rescued the growth defects of cln3D
SCB-HIS3 cells in the presence of both 10 mM and 30 mM of 3-
AT, whereas HOS3 gene knockout had a marginal but additive
effect. In contrast, the growth of pho85D cells was slightly rescued
by deletion of HOS3 but not RPD3 providing further evidence for
Pho85 acting specifically through Hos3. Because of difficulties in
detecting HDACs at promoters, we were unable to confirm these
observations in vivo.
We also performed co-immunoprecipitation assays using affinity
tagged RPD3 and HOS3 strains and observed an obvious decrease
in Rpd3 and Hos3 in Whi5 precipitates from strains harboring
increased levels of Pcl9, Cln2, or Cln3 cyclins (Figure 11A and
11B). Together, our genetic and biochemical results suggest that
Pho85 may preferentially influence Whi5-Hos3 activity, whereas
Cln3-Cdc28 is required for inhibition of both Rpd3 and Hos3.
Figure 6. Whi5-mediated transcriptional repression is antago-
nized by PHO85 and CDC28. A reporter gene consisting of eight LexA
binding sites flanked by the GAL1 promoter and the LacZ coding
sequence was constructed (pBA1976). b-galactosidase activity (upper
histogram) was measured in a wt strain (BY263) bearing the LacZ
reporter along with one of the following: a vector control (pBA230v); a
LexA expressing plasmid (pLexA; pBA1977); or a construct expressing a
LexA-Whi5 fusion protein (pLexA-WHI5; pBA1978). b-galactosidase
activities were also assayed (lower histogram) in a wt strain harboring
the LacZ reporter construct alone (vector control; pBA1976) or
overexpressing the G1 cyclins, PCL9 (pBA1974), CLN2 (pBA2247), or
CLN3 (pBA2248) in the presence of LexA-Whi5 (pBA1978) or LexA-
Whi5
12A (pBA1979) fusion proteins.
doi:10.1371/journal.pbio.1000188.g006
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PLoS Biology | www.plosbiology.org 9 September 2009 | Volume 7 | Issue 9 | e1000188Figure 7. Pho85 does not affect known Whi5 regulatory mechanisms. (A) Determination of relative Cdc28 and Pho85 kinase activity. In vitro
kinase assays using varying amounts of recombinant Cln2-Cdc28, Cln3-Cdc28, and Pcl9-Pho85 in the absence (lane 1–3) or presence of purified Whi5
(lanes 5–8) were conducted and the degree of Whi5 phosphorylation was determined by SDS-PAGE and autoradiography. Purified Whi5 and c-
32P-
ATP were incubated in the absence of kinase in lane 8, and lane 4 is empty. A 3 mM final concentration of Cln3-Cdc28 and Pcl9-Pho85 and a 60 nM
final concentration of Cln2-Cdc28 give similar amounts of
32P-incorporation in Whi5, although phosphorylation by Cln2-Cdc28 caused Whi5 to
migrate more slowly than Whi5 phosphorylated by Cln3-Cdc28 or Pcl9-Pho85. The concentration of kinase used in (B) was based on these
experiments. (B) Cln3-Cdc28 and Pcl9-Pho85 do not influence Whi5-SBF complex stability. A preassembled recombinant Whi5-Swi4
FLAG-Swi6 complex
bound to anti-FLAG resin was incubated with Cln2-Cdc28, Cln3-Cdc28, Pcl9-Pho85, or both Cln3-Cdc28 and Pcl9-Pho85 in the presence of
radiolabeled ATP. After washing, proteins in the bound and supernatant fractions were identified by autoradiography. (C) Subcellular localizationo f
Whi5 in cdk mutant strains. Wt (BY263), pho85D (BY391), and cdc28-4 strains (BY465) expressing WHI5
GFP from a methionine-repressible promoter
(pBA1981) were examined for Whi5
GFP fluorescence. Representative fields are shown.
doi:10.1371/journal.pbio.1000188.g007
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PLoS Biology | www.plosbiology.org 10 September 2009 | Volume 7 | Issue 9 | e1000188Figure 8. Whi5 function is dependent on HDAC activity. (A) Whi5 associates with Hos3 and Rpd3. Lysates prepared from the indicated
epitope-tagged HDAC strains (BY4309–4315) harboring a vector control (pEG-H) or construct expressing WHI5
GST (pBA1973) were incubated with
glutathione sepharose beads. Whi5
GST -HDAC interactions were detected by immunoblot using a-GST and a-PAP antibodies. (B) Hos3 and Rpd3
modulate Whi5 cell size effects. A plasmid expressing WHI5 (pBA1980) or vector control (pBA230v) were introduced into wt (BY263), hos3D (BY4293),
rpd3D (BY4294), and hos3D rpd3D (BY4295) strains, and cell size distributions were measured. Each panel corresponds to a specific mutant and wt
distributions are superimposed in each panel. The median cell volume based on three replicates was: 42.06 fl61.09 (wt+vector control, blue);
73.12 fl61.16 (wt+WHI5, black); 30.57 fl61.23 (hos3D+vector control, panel 1, red); 71.35 fl61.59 (hos3D+WHI5, panel 1, green); 51.20 fl61.73
(rpd3D+vector control, panel 2, red); 69.75 fl62.79 (rpd3D+WHI5, panel 2, green); 45.62 fl61.22 (hos3D rpd3D+vector control; panel 3, red);
50.26 fl61.14 (hos3D rpd3D+WHI5, panel 3, green).
doi:10.1371/journal.pbio.1000188.g008
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PLoS Biology | www.plosbiology.org 11 September 2009 | Volume 7 | Issue 9 | e1000188Figure 9. WHI5 toxicity is dependent on HOS3 and RPD3. (A) cln3D (BY4290), cln3D rpd3D (BY4297), cln3D hos3D (BY4296), and cln3D rpd3D
hos3D (BY4298) strains harboring a methionine-repressible WHI5 construct (pBA1975) or vector control (pBA228v) were spotted in serial 10-fold
dilutions on medium lacking methionine. In a similar experiment, pho85D (BY391), pho85D rpd3D (BY4300), pho85D hos3D (BY4299), and pho85D
rpd3D hos3D (BY4301) strains bearing a galactose-inducible WHI5 plasmid (pBA1973) or appropriate vector control (pEG-H) were spotted in serial 10-
fold dilutions on galactose-containing medium. Plates were incubated at 30uC for 48 h. (B) Deletion of HOS3 partially restores growth of a cln3D
pho85D strain. The indicated strains (BY263; BY4291, BY4292, BY4455–4461) were spotted in serial 10-fold dilutions on rich medium (YPED) and
incubated at 30uC for 48 h. (C) Deletion of RPD3 and HOS3 partially restore viability of a cln3D bck2D strain. The indicated strains (BY4741; BY2948,
BY4462–4468) were spotted in serial 10-fold dilutions on glucose-containing medium (YPED) to repress CLN3 expression. Strains were also spotted on
medium containing galactose as a control. Plates were incubated at 30uC for 72 h.
doi:10.1371/journal.pbio.1000188.g009
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Whi5 is a critical cell cycle regulator that links CDK activity in
G1 phase to the broad transcriptional program that accompanies
commitment to cell division. We provide substantial evidence that
the multifunctional Pho85 CDK is an important regulator of Whi5
activity and G1 phase-specific transcription including: (1) Whi5 is
phosphorylated and antagonized by Pho85 and is the first reported
substrate for the G1-specific CDK complex, Pcl9-Pho85; (2) the
activity of an SBF-dependent promoter is influenced by PHO85;
(3) the Pcl9 cyclin binds to SBF-regulated promoters; (4) the
repressor function of Whi5 is mediated through the HDACs Hos3
and Rpd3; and (5) HDAC-Whi5 association is regulated by G1-
specific forms of both the Pho85 and Cdc28 CDKs. We therefore
conclude that timely and efficient release from Whi5 inhibition
and subsequent G1/S cell cycle progression requires the concerted
activity of both Cdc28 and Pho85.
Several lines of evidence point to common roles for Pho85 and
Cdc28. For example, a burst of both G1-specific Cdc28 and
Pho85 activity is essential for cellular morphogenesis. A strain
lacking the G1-specific cyclins, CLN1, CLN2, PCL1, and PCL2,
undergoes a catastrophic morphogenic change and fails to
establish polarized cell growth and cytokinesis [30]. Consistent
with these observations, a chemical genomic analysis demonstrat-
ed that expression of genes involved in polarized cell growth was
sensitive to simultaneous inhibition of both kinases, but not either
single kinase [31]. A functional connection between Pho85 and
Cdc28 is further supported by independent genetic and biochem-
ical analyses that identify common targets phosphorylated by both
kinases [45,46,48,57–59].
Despite the clear functional overlap for G1-specific forms of
Cdc28 and Pho85 in controlling morphogenesis, up to now, a
direct role for Pho85 in cell cycle commitment and G1 phase-
specific transcription has remained unclear. We discovered that,
like Cdc28, Pho85 activates G1 transcription through inhibition of
the Whi5 repressor. While the two kinases collaborate to control
certain facets of Whi5 regulation, they are also specialized to
modulate Whi5 function by distinct mechanisms. We have defined
a novel HDAC-dependent mechanism that impinges on Whi5
function and implicates both Pho85 and Cdc28 as regulators of
this process.
On the basis of these and other observations, we propose that
Whi5 functional regulation involves perturbation of specific
HDAC-Whi5 interactions and requires the concerted activity of
both Cdc28 and Pho85 (summarized in Figure 12). Interestingly,
our genetic observations support a model whereby Pcl-Pho85
preferentially targets the Hos3-Whi5 interaction illustrating a
functional distinction between the two CDKs. While Pho85
associates with several cyclin subunits, only Pcl9 exhibits temporal
expression and localization patterns compatible with such a
function. PCL9 is expressed at the M/G1 phase transition and
encodes a short-lived protein localized exclusively to the nucleus in
early G1 phase [27,60,61]. Cln3 is also present in early G1 cells,
but shows a complex localization pattern, with significant retention
to the ER in early G1 cells, followed by chaperone-mediated
release into the nucleus in late G1 phase [62]. How the specific
features of Pcl9 and Cln3 localization might influence the timing
of HDAC inhibition remains to be explored.
The second component of Whi5 regulation is predicated on
previous studies indicating that G1/S gene expression is preceded
by Whi5-SBF complex dissociation and subsequent nuclear export
of Whi5 (Figure 12) [13]. Unlike early regulatory events, Cdc28
activity is both necessary and sufficient to drive these events since
neither SBF binding to Whi5 nor nuclear localization of Whi5 was
adversely affected in a pho85D mutant (Figure 7). Also, we are able
to detect binding of SBF in vivo to CLN2 promoters when PHO85
is deleted (Figure 3C). However, both purified Cln3-Cdc28 and
Pcl9-Pho85 failed to affect Whi5-SBF stability in vitro, while
complex disruption was effectively achieved in the presence of
Cln2-Cdc28 kinases (Figure 7). Cln3-Cdc28 and Pcl9-Pho85 may
have a more pronounced effect on the Whi5-SBF complex in vivo.
Figure 10. Repression of gene expression by Whi5 is dependent on HOS3 and RPD3. The growth defects of cln3D and pho85D strains can
be rescued by removing RPD3 and HOS3 in SCB-driven gene expression. Wt (BY4302), cln3D (BY4303), pho85D (BY4304), cln3D rpd3D (BY4297), cln3D
hos3D (BY4296), cln3Drpd3Dhos3D (BY4298), pho85Drpd3D (BY4300), pho85Dhos3D (BY4299), and pho85Drpd3Dhos3D (BY4301) strains harboring an
integrated SCB-HIS3 reporter were spotted in serial 10-fold dilutions on histidine-containing medium or media lacking histidine and supplemented
with 10 or 30 mM 3-AT. Plates were incubated at 30uC for 48 h.
doi:10.1371/journal.pbio.1000188.g010
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of HDAC interactions while physical interactions with SBF and
nuclear export are optimally mediated by the late G1 CDKs,
Cln1- and Cln2-Cdc28. Indeed, recent work reveals activation of
CLN2 expression while Whi5 remains bound to the promoter (H.
Wang, L.B. Carey, Y. Cai, H. Wijnen, and B. Futcher, personal
communication). Such a mechanism may serve to sharpen the
onset, as opposed to the timing, of G1/S gene expression thus
ensuring a sustained transcriptional burst and irreversible
commitment to cell division [13]. Consistent with this idea, recent
analysis of cyclin gene expression using a single cell assay affirms
that positive feedback involving the Cln1 and Cln2 cyclins induces
the G1/S regulon, and that this regulatory feedback is important
for maintaining coherence of gene expression at Start [63].
SBF promoter recruitment depends on a series of well-
organized chromatin remodeling events [7,36]. SBF, in turn,
regulates the recruitment of the general transcription machinery
via a two-step process beginning with the mediator complex
followed by CDK-dependent recruitment of RNA PolII, TFIIB,
and TFIIH [9]. Previous studies suggested that this CDK
requirement stems from Whi5, which in its unphosphorylated
state, remains bound to SBF and occludes the basal transcription
machinery from binding specific promoters [13]. We have
extended this model to include a role for HDAC activity. We
predict that Hos3 and Rpd3 contribute to Whi5 repression by
preventing holoenzyme access to chromatin. During states of high
CDK activity, Cdc28 and Pho85 abrogate Whi5-HDAC and
Whi5-SBF interactions and initiate transcription. Consistent with
our model, Pcl9 and Cln3 cyclins localize to G1 promoters and
Whi5 remains associated with G1-specific promoters in the
absence of HDAC-promoter interactions (Figure 3; H. Wang,
L.B. Carey, Y. Cai, H. Wijnen and B. Futcher, personal
communication). However, Whi5 may also repress transcription
by additional mechanisms since its activity is partially retained in
hos3D rpd3D mutants (Figure 9).
Rpd3 is a well-characterized HDAC that accomplishes most of its
functions as part of a large protein complex [37]. The Rpd3-Sin3
deacetylase complex has long been implicated as a cell cycle
regulator required for silencing HO gene expression to prevent
mating type switching in newly budded cells [64,65]. Our
observations that Whi5 associates with Rpd3 and our genetic data
linking G1 Cdks, Whi5, and Rpd3 reveal a more general role for
Rpd3inG1/S-phasespecifictranscription.Thesedataareconsistent
withobservationsfromFutcherandcolleaguesthattheRpd3protein
can be detected at the CLN2 promoter and that the amount of Rpd3
at the promoter is decreased when CLN3 is induced (H. Wang, L.B.
Carey, Y. Cai, H.Wijnen and B. Futcher, personal communication).
The Rpd3-Sin3 HDAC has also been connected to G1 transcription
factors through the interaction of Sin3 with Stb1, a Swi6-binding
protein [66–68]. Both Stb1 and Sin3 are required for repression of
G1 transcription early in G1 phase [68]. Unlike Rpd3, Hos3 is
largely uncharacterized, although a recent study suggests a role for
Hos3inyeast apoptosis uponexposuretooxidative radicals[69].We
have uncovered an additional role for Hos3 in Whi5-mediated
transcriptional repression.
A question that arises from our observations is what advantage
does combinatorial kinase regulation impart on specific biological
processes such as G1/S cell cycle progression? Contributions from
multiple CDKs may provide the precision and accuracy necessary
for rapid definitive decisions that irreversibly affect cellular fate.
Indeed, distributive multisite phosphorylation mechanisms exhibit
ultrasensitivity with respect to kinase concentration, thereby
creating a ‘‘switch-like’’ behavior in biological circuits [70]. Since
cell cycle transitions typically display switch-like attributes,
multisite phosphorylation by various kinase combinations may
prove to be a rule rather than the exception amongst CDK targets,
including key cell cycle regulators such as Whi5. In fact, a recent
Figure11.CDKactivityantagonizesWhi5-HDACinteractions.(A)
Pho85 and Cdc28 activity inhibits interaction between Whi5 and Rpd3.
PCL9
FLAG (pBA1974), CLN2
FLAG (pBA2247), CLN3
FLAG (pBA2248), or a vector
control (pMT3164)were introducedinto a strainharboringRPD3
TAPatthe
chromosomal locus (BY4315) and a WHI5
GST plasmid (pBA1973). Cyclin
expression was confirmed by immunoblot using anti-FLAG antibodies.
Lysates were incubated with glutathione sepharose beads. Whi5
GST-
Rpd3
TAP interactions were detected by immunoblot using a-GST and a-
PAP antibodies, (B) Pho85 and Cdc28 activity inhibits interaction of Whi5
and Hos3. Experiments were conducted as described in (A) but using a
strain bearing HOS3
TAP at the chromosomal locus.
doi:10.1371/journal.pbio.1000188.g011
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spaced consensus sites for Cdc28 substrates in yeast, a pattern that
proved predictive of likely CDK targets [71].
Although kinase combinations are likely necessary for cell cycle
regulation, the contribution of each individual kinase may vary
depending on specific signals and environmental stimuli. In certain
environments, Pcl-Pho85 may have more dramatic, condition-
specific effects on Whi5 function than Cdc28 analogous, perhaps,
to the regulation of Rb that is required for quiescence and
prevention of apoptosis [72,73]. Previous studies indicate that
Whi5 localizes to nuclei in stationary phase cells suggesting that
Whi5 may also play a role in G0 [13]. Interestingly, Pho85 is
required for survival in starvation conditions and plays an
important role during stationary phase [74–76]. Furthermore,
CDK5, the mammalian Pho85 homolog, induces apoptosis in
neuronal cells via Rb phosphorylation [77]. Whether Whi5
activity is more prominently affected by Pcl-Pho85 in response
to stationary or stress conditions requires additional investigation.
Similarities between metazoan and yeast cell cycle regulation are
increasingly evident as we continue to characterize Whi5 function.
For example, similar to proposed Pcl9/Cln3 ‘‘early’’ phase regulation
(Figure 12),cyclinD-CDK4/6phosphorylatesRb topromote HDAC
dissociation and E2F transcriptional activation. E2F activation then
l e a d st oc y c l i nEe x p r e s s i o n ,w h i c h ,s i m i l a rt oC l n 1 / 2‘ ‘ l a t e ’ ’p h a s e
regulation(Figure12), may establishapositivefeedback loopwhereby
cyclinE-CDK2 activity disrupts Rb-promoter interactions and
stimulates G1-transcription further [15]. Despite these similarities,
t h ei m p o r t a n c eo fm u l t i p l er e g u l a t o r yc o m p o n e n t si nb o t hy e a s ta n d
mammalian systems remains poorly understood and may be most
fruitfully dissected using the yeast model.
Materials and Methods
Yeast Strains, Growth Conditions, and Plasmids
The S. cerevisiae strains used are listed in Table 1. All gene
disruptions and integrations were achieved by homologous
recombination at their chromosomal loci by standard PCR-based
methods and confirmed by PCR with flanking primers [78].
Standard methods and media were used for yeast growth and
transformation. Two percent of galactose in the media was used to
induce the expression of genes under the GAL1 promoter.
Synthetic minimal medium with appropriate amino acid supple-
ments was used for cells containing plasmids. Appropriate
amounts of 3-AT were added to SD-HIS plates to assess the
expression of HIS3 reporter genes. 10-fold serial dilutions (5–10 ml)
of yeast cells were spotted onto plates with appropriate nutrition
conditions to assess growth. Plasmids used in this study are listed in
Table 2. In most cases, a DNA insert was amplified by PCR and
inserted into a linearized vector by homologous recombination in
yeast. Details of construction will be provided upon request.
Figure 12. Model for CDK-dependent regulation of Whi5 activity and G1/S-specific transcription. Shown is a schematic of the disruption
of interactions between Whi5 and the HDACs, Hos3 and Rpd3, by Cln3-Cdc28 and Pcl9-Pho85-dependent phosphorylation, leading to transcription of
G1 genes, including the CLN1 and CLN2 cyclins. Whi5 is then further phosphorylated by Cln1- and Cln2-Cdc28 complexes leading to complete
disassembly of the Whi5-SBF complex, Whi5 nuclear export and a burst in gene expression necessary for the G1/S phase transition.
doi:10.1371/journal.pbio.1000188.g012
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Strain Genotype Source or Reference
BY186 BY263 MATa swi4DHIS3 [82]
BY263 MATa trp1 leu2 his3 ura3 lys2 ade2 [29]
BY391 BY263 MATa pho85DLEU2 [29]
BY451 BY263 MATa pcl2DLYS2 [25]
BY462 MATa leu2 his3 ura3 cdc28-13 M. Tyers
BY465 MATa leu2 his3 ura3 cdc28-4 M. Tyers
BY490 BY263 MATa pho80DHIS3 [25]
BY628 BY263 MATa pcl1DLEU2 [25]
BY653 BY263 MATa cln3DURA3 This study
BY694 BY263 MATa pcl9DHIS3 [25]
BY760 BY263 MATa pcl1DLEU2 pcl9DHIS3 [25]
BY764 BY263 MATa pcl1DLEU2 pcl2DLYS2 pcl9DHIS3 [25]
BY867 BY263 MATa pho85DTRP1 [25]
BY1446 BY263 MATa cln3DURA3 pho85DLEU2 whi5DKAN
R This study
BY1502 Y2454 MATa pho85DLEU2 [74]
BY2507 BY4741 MATa WHI5
myc::KAN
R M. Tyers
BY2948 BY4741 MATa cln3DHPH
R bck2DNAT
R pGAL-CLN3 URA3 This study
BY4148 BY4741 MATa GALpr-HA-CDC20::KAN
R pho85DNAT
R PCL9
myc This study
BY4151 BY4741 MATa GALpr-HA-CDC20::KAN
R This study
BY4152 BY4741 MATa WHI5
myc::KAN
R pho85DNAT
R This study
BY4153 BY4741 MATa WHI5
myc::KAN
R cdc28-4 This study
BY4154 BY4741 MATa WHI5
myc::KAN
R cdc28-4 pho85DNAT
R This study
BY4242 BY4741 MATa GALpr-HA-CDC20::KAN
Rcln1DNAT
R cln2DHPH
R This study
BY4269 BY4741 MATa GALpr-HA-CDC20::KAN
Rcln3DURA3 pho85DLEU2
R This study
BY4270 BY4741 MATa GALpr-HA-CDC20::KAN
Rcln3DURA3 pho85DLEU2 whi5DKAN
R This study
BY4273 BY4741 MATa GALpr-HA-CDC20::KAN
Rcln3DURA3 This study
BY4274 BY4741 MATa GALpr-HA- CDC20::KAN
R pho85DLEU2 This study
BY4288 BY4741 MATa WHI5
myc::KAN
R cln3DLEU2 This study
BY4289 BY4741 MATa WHI5
myc::KAN
R cln1DNAT
R cln2DHPH
R This study
BY4290 BY263 MATa cln3DTRP1 This study
BY4292 BY263 MATa cln3DURA3 pho85DLEU2 whi5DKAN
R This study
BY4293 BY263 MATa hos3DKAN
R This study
BY4294 BY263 MATa rpd3DNAT
R This study
BY4295 BY263 MATa hos3DKAN
R rpd3DNAT
R This study
BY4296 BY263 MATa cln3DTRP1 hos3DKAN
R This study
BY4297 BY263 MATa cln3DTRP1 rpd3DNAT
R This study
BY4298 BY263 MATa cln3DTRP1 hos3DKAN
R rpd3DNAT
R This study
BY4299 BY263 MATa pho85DLEU2 hos3DKAN
R This study
BY4300 BY263 MATa pho85DLEU2 rpd3DNAT
R This study
BY4301 BY263 MATa pho85DLEU2 hos3DKAN
R rpd3DNAT
R This study
BY4302 BY4741 MATa hoD::SCB:HIS3::URA3 This study
BY4303 BY4741 MATa hoD::SCB:HIS3::URA3 cln3DNAT
R This study
BY4304 BY4741 MATa hoD::SCB:HIS3::URA3 pho85DLEU2 This study
BY4305 BY4741 MATa hoD::SCB:HIS3::URA3 cln3DNAT
R pho85DLEU2 This study
BY4306 BY4741 MATa hoD::SCB:HIS3::URA3 cln3DNAT
R pho85DLEU2 whi5DKAN
R This study
BY4307 BY4741 MATa hoD::SCB:HIS3::URA3 cln3DNAT
R whi5DKAN
R This study
BY4308 BY4741 MATa hoD::SCB:HIS3::URA3 pho85DLEU2 whi5DKAN
R This study
BY4309 BY4741 MATa HOS1
TAP::HIS3 This study
BY4310 BY4741 MATa HOS2
TAP::HIS3 This study
BY4311 BY4741 MATa HOS3
TAP::HIS3 This study
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The in vitro protein kinase assays monitored the incorporation
of [
32P] transferred from c-
32P-ATP to purified recombinant
GST-Whi5. The reaction mixture for assays shown in Figure 2A
contained 50 mM Tris-HCl (pH 7.5), 1 mM DTT, 10 mM
MgCl2, and 1 mM ATP (including 20 mCi c-
32P-ATP) and
0.2 mg GST-Whi5 in 20 ml of total volume. 2 ml of a purified
recombinant kinase (0.4 mg–0.8 mg) was added to the mixture and
incubated at 30uC for 30 min. Purification of Cln and Pcl CDKs
from insect cell expression systems have been previously described
[13,46]. Whi5 was then analyzed by SDS-PAGE and autoradi-
ography. Kinase assays on immunoprecipitated proteins from
yeast cell extracts were performed as described [13]. Kinase assays
preceding the Whi5-SBF dissociation assay (Figure 7) were
performed as described above except that 200 mM c-
32P-ATP
was used instead of 1 mM. The final concentration of Cln3 and
Pcl9 was 3 mM, and the final concentration of Cln2 was 60 nM
(50-fold less).
Quantitative b-Galactosidase Assays
Liquid b-galactosidase assays were performed as described [29].
Strains carrying appropriate plasmids were grown in synthetic
minimal medium to mid-log phase, transferred to synthetic
galactose medium, and incubated for 4 h. Cells were harvested
and broken in lysis buffer (100 mM Tris-HCl [pH 8.0], 1 mM
DTT, and 20% glycerol with protease inhibitors) with glass beads.
The b-galactosidase activity was determined by adding 100 mlo f
total cell extract to 0.9 ml of Z buffer (100 mM Na2PO4,4 0m M
NaHPO4, 10 mM KCl, 1 mM MgSO4, and 0.027% b-mercap-
toethanol) and 200 ml ONPG (4 mg/ml) (Sigma). Units of b-
galactosidase activity were determined as described [29].
Whi5 Dissociation with SBF Complex In Vitro
The protein binding assay essentially followed the procedures
described previously [13]. Briefly, 1 ml of insect cell lysate expressing
SBF (Swi6-Swi4
FLAG) was mixed with 1 ml of purified GST-Whi5
(,0.1 mg) and 7 ml of M2 anti-FLAG resin (Sigma) in 8 mlo fk i n a s e
buffer (50 mM Tris-HCl [pH 7.5], 1 mM DTT, and 10 mM
MgCl2). The mixture was incubated at 4uC for 1 h with mixing.
The beads bound to the SBF-Whi5 complex were then washed three
times with kinase buffer, and mixed with various cyclin dependent
kinases in kinase buffer with 0.2 mM ATP in a 20 mlv o l u m e .T h e
kinase reaction was incubated at 30uC for 1 h. The soluble portion
wastaken out and mixed with 20 mlo f2 6SDS-PAGEloadingbuffer.
The beads in the tube were washed three times with kinase buffer
before mixing with 15 mlo f2 6SDS-PAGE loading buffer.
Liquid Growth Assays
Strains containing galactose-inducible plasmids were grown to
saturation in 2% raffinose media for 48 h. Expression of plasmids
were induced by transferring into 2% raffinose 2% galactose
media and liquid growth assays were performed as previously
described over 36 h using a Tecan GENios microplate reader
(Tecan) [79]. Average doubling (AveG) for each culture was
calculated as previously described [79]. Growth rate for each
mutant was calculated relative to the AvgG of the wt strain.
Strain Genotype Source or Reference
BY4312 BY4741 MATa HDA1
TAP::HIS3 This study
BY4313 BY4741 MATa HDA2
TAP::HIS3 This study
BY4314 BY4741 MATa HDA3
TAP::HIS3 This study
BY4315 BY4741 MATa RPD3
TAP::HIS3 This study
BY4454 BY263 MATa whi5DKAN
R This study
BY4455 BY263 MATa cln3DURA3 pho85DLEU2 hos1DHIS5 This study
BY4456 BY263 MATa cln3DURA3 pho85DLEU2 hos2DHIS5 This study
BY4457 BY263 MATa cln3DURA3 pho85DLEU2 hos3DNAT
R This study
BY4458 BY263 MATa cln3DURA3 pho85DLEU2 rpd3DNAT
R This study
BY4459 BY263 MATa cln3DURA3 pho85DLEU2 hda1DHIS5 This study
BY4461 BY263 MATa cln3DURA3 pho85DLEU2 hos3DKAN
R rpd3DNAT
R This study
BY4462 BY2948 whi5DKAN
R This study
BY4463 BY2948 hos1DKAN
R This study
BY4464 BY2948 hos2DKAN
R This study
BY4465 BY2948 hos3DKAN
R This study
BY4466 BY2948 rpd3DHIS5 This study
BY4467 BY2948 hda1DHIS5 This study
BY4468 BY2948 hos3DKAN
R rpd3DHIS5 This study
BY4541 BY263 pho85DLEU2 whi5DKAN
R This study
BY4542 BY263 cln3DTRP1 whi5DKAN
R This study
BY4741 MATa leu2D0 his3D1 ura3D0 met15D0 —
Y2454 MATa mfa1D MFApr-HIS3 can1D his3D1 leu2D0 lys2D0 [83]
Of the wt strains used in this study, both BY263 and BY4741 are derived from S288C background. All the other strains are derived from these two strains. BY263 is an
ssd1-d strain; BY4741 is an SSD1-V strain and is the parent strain for the yeast deletion consortium. Y2454 is congenic to BY4741 and is the parent for query strains used
in synthetic genetic array (SGA) experiments.
doi:10.1371/journal.pbio.1000188.t001
Table 1. Cont.
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The localization of Whi5-GFP was monitored in wt, cdc28-4,a n d
pho85D strains. Cells expressing pMET-GFP-WHI5 were grown to
log phase in synthetic glucose medium without methionine. Cells
were observed at a magnification of 1,0006using Nomarski optics
and fluorescence microscopy and photographed by a Cascade 512B
high-speed digital camera (Roeper Scientific) mounted on a Leica
DM-LB microscope. Images were captured and analyzed by
MetaMorph software (Universal Imaging Media).
ChIP
The pho85D PCL9
MYC GALpr-CDC20 and pho85Dwhi5DPCL9
MYC
GALpr-CDC20 cells were grown in YP-Galactose (YPG) medium to
an optical density (OD600) of 0.4, blocked at M phase by growing in
YPED medium for 3 h, and released into YPG medium. Samples
were taken every 15 min after release and cross-linked with a final
concentration of 1% formaldehyde. Wt and swi4D strains (for
controls) were grown to OD600 of 0.6 in YPD. Formaldehyde cross-
linking and preparation of whole-cell extracts were performed as
previously described [80]. Immunoprecipitation were performed
using 1:200 dilution of a-myc monoclonal antibody (9E10), a-Swi6
or a-Swi4 polyclonal antibodies. The precipitates were washed
twice with lysis buffer, once with LiCl detergent and once with Tris-
buffered saline and processed for DNA purification. Enrichment at
the CLN2 promoter sequence was quantified with real-time PCR,
using a dual fluorogenic reporter TaqMan assay in an ABI PRISM
7500HT Sequence Detection System as previously described [13].
Other Materials and Methods
Recombinant GST-Pcl1 and GST-Whi5 were produced in a
BL21 bacterial expression strain; other recombinant proteins were
produced in insect cells infected with Baculovirus expression
vectors [11,46,73]. Proteins were detected with 9E10 anti-Myc,
12C5 anti-HA, and M2 anti-FLAG monoclonal antibodies. FACS
analysis of DNA content and cell size measurements were
described previously [81].
Supporting Information
Figure S1 Expression levels of epitope-tagged Whi5 and
Pcls. Whi5 and Pcl abundance in the indicated strains was
determined by immunoblotting. Cyclin proteins were detected
using 12CA5 anti-HA antibodies whereas Whi5 protein was
detected using anti-GST antibodies.
Found at: doi:10.1371/journal.pbio.1000188.s001 (0.93 MB EPS)
Table S1 List of 53 synthetic lethal interactions involv-
ing PHO85 that are not rescued by deletion of WHI5.
Found at: doi:10.1371/journal.pbio.1000188.s002 (0.07 MB
DOC)
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